These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4997444)

  • 1. [Microfilaria of Dirofilaria corynodes (Linstow, 1899) as a new contaminating agent of cell tissue cultures for the production of vaccine against poliomyelitis].
    Furmaga S; Gundlach JL; Grzybek D; Woźniak M
    Wiad Parazytol; 1971; 17(1):65-73. PubMed ID: 4997444
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between detectable microfilaremia and total population of microfilariae in monkeys infected with Dirofilaria corynodes.
    Pacheco G; Orihel TC
    J Parasitol; 1968 Dec; 54(6):1234-5. PubMed ID: 4990411
    [No Abstract]   [Full Text] [Related]  

  • 3. Present state and developments in the production of inactivated poliomyelitis vaccine.
    van Wezel AL
    Dev Biol Stand; 1981; 47():7-13. PubMed ID: 6262162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of proflavine-sensitized poliovirus strains for determination of the range of susceptible animals.
    Koroleva GA; Lashkevich VA; Voroshilova MK
    Acta Virol; 1973 Jul; 17(4):310-8. PubMed ID: 4148211
    [No Abstract]   [Full Text] [Related]  

  • 5. The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine.
    Montagnon BJ; Fanget B; Nicolas AJ
    Dev Biol Stand; 1981; 47():55-64. PubMed ID: 6785126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal cell strains as substitutes for primary monkey cultures in testing Salk and other inactivated vaccines for persistent viruses.
    Farrell LN
    Prog Immunobiol Stand; 1967; 3():27-33. PubMed ID: 4314429
    [No Abstract]   [Full Text] [Related]  

  • 7. Killed poliovaccine: an evaluation of safety testing.
    van Steenis G; van Wezel AL
    Dev Biol Stand; 1981; 47():143-50. PubMed ID: 6262145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposals on the control of VERO cells used to prepare inactivated poliomyelitis vaccine.
    Ménetrat JL; Chaniot S; Lefrançois S; Canale A; Chippaux A
    Dev Biol Stand; 1981; 47():163-7. PubMed ID: 6785125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine.
    Wood DJ; Heath AB; Kersten GF; Hazendonk T; Lantinga M; Beuvery EC
    Biologicals; 1997 Mar; 25(1):59-64. PubMed ID: 9167009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dirofilaria corynodes (Von Linstow, 1899): morphology and life history.
    Orihel TC
    J Parasitol; 1969 Feb; 55(1):94-103. PubMed ID: 5764050
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on new attenuated strains of type III live poliomyelitis vaccine. I. Development of a new type III attenuated poliovirus.
    Chin Med J (Engl); 1980 Sep; 93(9):583-90. PubMed ID: 6253236
    [No Abstract]   [Full Text] [Related]  

  • 12. The monitoring of antigen levels during inactivated poliovirus vaccine production: evaluation of filtration techniques.
    Moynihan M; Petersen I
    Dev Biol Stand; 1981; 50():243-8. PubMed ID: 6804290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The suitability of silvered leaf monkey (Presbytis cristatus) kidney cell cultures for testing poliovirus vaccines.
    Thayer JR
    Aust J Exp Biol Med Sci; 1965 Dec; 43(6):803-8. PubMed ID: 4287195
    [No Abstract]   [Full Text] [Related]  

  • 14. Poliovaccines: lessons learnt and forgotten.
    Wyatt HV
    Hist Philos Life Sci; 1995; 17(1):91-112. PubMed ID: 8552753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of some possibilities of producing type 3 vaccine poliovirus with greater genetic stability. I. Preliminary experiments with passage variants.
    Elbert LB; Chumakov MP; Krutyanskaya GL; Ralph NM; Tyufanov AV
    Acta Virol; 1968 May; 12(3):193-202. PubMed ID: 4385148
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell substrate for killed poliovaccine production.
    Beale AJ
    Dev Biol Stand; 1981; 47():19-23. PubMed ID: 6262147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A microfilaria contaminating a monkey kidney cell suspension.
    PRIER JE; LEBEAU RW
    J Am Vet Med Assoc; 1958 Jul; 133(2):125-6. PubMed ID: 13563301
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity of trypsin treated type 2 and type 3 poliovirus in rats.
    Kersten GF; Lantinga M; Hazendonk T; Beuvery EC
    Biologicals; 1995 Jun; 23(2):179-83. PubMed ID: 7546661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virologic control of monkeys used for the production of poliomyelitis virus vaccine.
    Osterhaus AD; van Steenis G
    Dev Biol Stand; 1981; 47():157-61. PubMed ID: 6785124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of inactivated poliovirus vaccine derived from Sabin strains.
    Simizu B; Abe S; Yamamoto H; Tano Y; Ota Y; Miyazawa M; Horie H; Satoh K; Wakabayashi K
    Biologicals; 2006 Jun; 34(2):151-4. PubMed ID: 16679028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.